September 2, 2016

UPDATE ON MYLAN LABS $MYL

This post was just published on ZYX Buy Change Alert.

MYL is falling again on news of a Senator posting on her website misclassification of EpiPen for Medicaid.

Even if EpiPen prices cut further, this stock is easily worth north of $48.

Due to increased volatility, the best way for those who can handle additional risk is to trade without a stop. There is nothing worse than stop getting hit just to watch the stock go right back up.

Those who cannot handle additional risk may consider reducing the quantity from the maximum recommended 30% of the full core position size.

… Please click here or the title below to read more.

September 2, 2016

WEEKLY MARKET DIGEST: JOB GROWTH COOLS; OIL, GOLD, BONDS, AND STOCKS VULNERABLE $DIA $GLD $QQQ $SLV $SPY $TBF $TBT $USO $GDX $GDXJ $JNUG $UUP

WEEKLY MARKET DIGEST: JOB GROWTH COOLS; STOCKS, BONDS, OIL AND GOLD VULNERABLE $DIA $GLD $QQQ $SLV $SPY $TBF $TBT $USO $GDX $GDXJ $JNUG $UUP $VXX

Weekly Digest from The Arora Report is popular among serious investors and money managers because they have found studying insights from the prior week gives them an edge over the coming weeks. Here is the day by day rundown from the morning capsules made available every morning before the market open in the Real Time Feeds to the paying subscribers of The Arora Report.

Please scroll down for the section What To Do Now.